Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Cash from Operations (2019 - 2025)

AVITA Medical (RCEL) has disclosed Cash from Operations for 5 consecutive years, with 5438000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 32.71% year-over-year to 5438000.0, compared with a TTM value of 31195000.0 through Dec 2025, up 36.26%, and an annual FY2025 reading of 31195000.0, up 36.26% over the prior year.
  • Cash from Operations was 5438000.0 for Q4 2025 at AVITA Medical, down from 5219000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 2777000.0 in Q3 2022 and bottomed at 20864000.0 in Q1 2024.
  • Average Cash from Operations over 4 years is 8577187.5, with a median of 9023500.0 recorded in 2023.
  • The sharpest move saw Cash from Operations plummeted 223.15% in 2023, then surged 50.59% in 2025.
  • Year by year, Cash from Operations stood at 3436000.0 in 2022, then tumbled by 216.15% to 10863000.0 in 2023, then rose by 25.61% to 8081000.0 in 2024, then soared by 32.71% to 5438000.0 in 2025.
  • Business Quant data shows Cash from Operations for RCEL at 5438000.0 in Q4 2025, 5219000.0 in Q3 2025, and 10229000.0 in Q2 2025.